Skip to content

Immediate Protected Weight Bearing Versus Conventional Non-Weight Bearing After Surgical Fixation of Unstable Ankle Fractures

Immediate Protected Weight Bearing Versus Conventional Non-Weight Bearing After Surgical Fixation of Unstable Ankle Fractures: A Prospective Randomized Controlled Trial

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07814638
Enrollment
102
Registered
2026-09-11
Start date
2023-01-15
Completion date
2026-01-15
Last updated
2026-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ankle Fractures, Unstabel Ankle Fractures

Keywords

Ankle fracture, Immediate protected weight bearing, Rehabilitation, Walker boot, Randomized controlled trial

Brief summary

This prospective randomized controlled trial evaluates the safety and effectiveness of immediate protected weight bearing following surgical fixation of unstable ankle fractures. Participants are randomized to immediate protected weight bearing from the first postoperative day using a Walker boot and crutches or conventional non-weight bearing for six weeks. Functional outcome (OMAS), pain (VAS), ankle range of motion, quality of life (SF-12), and postoperative complications are assessed over 12 months.

Interventions

OTHERImmediate protected weight bearing

Immediate protected weight bearing from postoperative day 1 using a Walker boot and crutches

OTHERRehabilitation

Standardised rehabilitation after surgery

Sponsors

Consorci Sanitari Integral
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Unstable ankle fracture requiring ORIF. * Written informed consent.

Exclusion criteria

* Psychiatric disorder. * Pre-existing mobility limitation. * Cognitive impairment. * BMI \>30 kg/m². * Poorly controlled type 2 diabetes. * Soft tissue injury requiring external fixation. * Gustilo II/III open fractures. * Unstable fixation. * Refusal/inability to consent or allow anonymized data use. * Any condition compromising safety or validity.

Design outcomes

Primary

MeasureTime frame
Olerud-Molander Ankle Score (OMAS).6 weeks, 12 weeks, 6 months and 12 months after surgery

Secondary

MeasureTime frame
Visual Analogic Scale (VAS) for pain6 weeks, 12 weeks, 6 months and 12 months.
SF-12 quality of life6 weeks, 12 weeks, 6 months and 12 months.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 12, 2026